FindTrial
Sign In

Clinical study on the severity of diseases in patients infected with Chlamydia psittaci

A clinical study on the severity score of patients infected with Chlamydia psittaci

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128089
Enrollment
Unknown
Registered
2026-07-14
Start date
2026-07-14
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever and cough

Interventions

Patients infected with Chlamydia psittaci:None

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Men or women over the age of 18 are eligible; 2.Patients diagnosed with Chlamydia psittaci infection; 3.Intact clinical data;

Exclusion criteria

Exclusion criteria: 1.Persons under the age of 18; 2.Combine other clearly infected cases (bacterial/viral/fungal); 3.Severe immune impairment (defined as the need for continuous biological or chemical treatment, prednisolone > 20 mg/day for 14 days or longer, uncontrolled HIV/AIDS, hematological malignancies, and organ transplant recipients);

Design outcomes

Primary

MeasureTime frame
tracheal intubation;ICU occupancy rate;—

Countries

China

Contacts

Public ContactYing He

The Second Xiangya Hospital of Central South University

yinghe8905@163.com+86 183 9090 8720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026